Broderick Brian C Novo Nordisk A S Transaction History

Broderick Brian C

$470 Million
Q3 2024

A detailed history of Broderick Brian C transactions in Novo Nordisk A S stock. As of the latest transaction made, Broderick Brian C holds 6,091 shares of NVO stock, worth $532,170. This represents 0.15% of its overall portfolio holdings.

Number of Shares

6,091

Previous 6,440 5.42%

Holding current value

$532,170

Previous $919,000 21.11%

% of portfolio

0.15%

Previous 0.2%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$119.07 - $145.42 $41,555 - $50,751	-349 Reduced 5.42%	6,091 $725,000
Q2 2024 Aug 12, 2024	SELL	$122.71 - $146.91 $43,562 - $52,153	-355 Reduced 5.22%	6,440 $919,000
Q1 2024 May 03, 2024	SELL	$102.11 - $135.92 $90,367 - $120,289	-885 Reduced 11.52%	6,795 $872,000
Q4 2023 Feb 13, 2024	SELL	$87.78 - $105.45 $39,501 - $47,452	-450 Reduced 5.54%	7,680 $794,000
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $347,390 - $762,242	3,820 Added 88.63%	8,130 $739,000
Q2 2023 Aug 11, 2023	SELL	$155.98 - $172.65 $15,597 - $17,265	-100 Reduced 2.27%	4,310 $697,000
Q1 2023 May 10, 2023	SELL	$132.34 - $159.14 $16,542 - $19,892	-125 Reduced 2.76%	4,410 $701,000
Q3 2022 Nov 08, 2022	SELL	$95.28 - $116.93 $15,721 - $19,293	-165 Reduced 3.51%	4,535 $452,000
Q2 2022 Jul 19, 2022	SELL	$103.24 - $121.81 $10,324 - $12,181	-100 Reduced 2.08%	4,700 $524,000
Q1 2022 May 17, 2022	SELL	$93.1 - $112.54 $17,223 - $20,819	-185 Reduced 3.71%	4,800 $533,000
Q4 2021 Feb 08, 2022	BUY	$95.88 - $117.08 $87,250 - $106,542	910 Added 22.33%	4,985 $558,000
Q3 2021 Nov 10, 2021	SELL	$84.42 - $106.62 $16,884 - $21,324	-200 Reduced 4.68%	4,075 $391,000
Q2 2021 Aug 09, 2021	SELL	$67.66 - $84.76 $3,383 - $4,238	-50 Reduced 1.16%	4,275 $358,000
Q1 2021 May 17, 2021	SELL	$67.06 - $75.82 $5,029 - $5,686	-75 Reduced 1.7%	4,325 $292,000
Q4 2020 Feb 16, 2021	SELL	$63.89 - $73.8 $7,986 - $9,225	-125 Reduced 2.76%	4,400 $308,000
Q2 2020 Jul 28, 2020	SELL	$58.54 - $67.94 $13,171 - $15,286	-225 Reduced 4.74%	4,525 $296,000
Q1 2020 May 07, 2020	SELL	$49.46 - $64.78 $1,236 - $1,619	-25 Reduced 0.52%	4,750 $286,000
Q3 2019 Nov 04, 2019	SELL	$47.54 - $53.43 $4,754 - $5,343	-100 Reduced 2.05%	4,775 $247,000
Q2 2019 Jul 24, 2019	SELL	$46.79 - $52.47 $5,380 - $6,034	-115 Reduced 2.3%	4,875 $248,000
Q1 2019 Apr 29, 2019	SELL	$46.36 - $52.63 $6,954 - $7,894	-150 Reduced 2.92%	4,990 $261,000
Q2 2018 Jul 30, 2018	SELL	$44.29 - $50.42 $19,930 - $22,689	-450 Reduced 8.05%	5,140 $237,000
Q1 2018 Apr 24, 2018	SELL	$48.49 - $58.14 $11,395 - $13,662	-235 Reduced 4.03%	5,590 $275,000
Q4 2017 Feb 02, 2018	SELL	$47.53 - $53.73 $7,604 - $8,596	-160 Reduced 2.67%	5,825 $313,000
Q3 2017 Oct 26, 2017	BUY	$41.15 - $49.22 $246,282 - $294,581	5,985	5,985 $288,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Broderick Brian C, based on Form 13F filings with the SEC.

News

Stay updated on Broderick Brian C with notifications on news.

Account

Broderick Brian C Novo Nordisk A S Transaction History